Where is vitamin K synthesized in the gastrointestinal tract?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vitamin K Synthesis in the Gastrointestinal Tract

Vitamin K2 (menaquinones) is synthesized by intestinal bacteria, including E. coli, primarily in the colon and terminal ileum, where it contributes to meeting human vitamin K requirements. 1

Bacterial Production Sites

Colon (Primary Site)

  • Many intestinal bacteria synthesize vitamin K2 (menaquinones), but not vitamin K1 (phylloquinone), with E. coli being a key producer. 1
  • The colon harbors members of the genus Bacteroides that synthesize very long-chain menaquinones (MK-10 through MK-13). 2
  • Colonic absorption of bacterially synthesized vitamin K2 occurs via passive, nonsaturable diffusion that is not energy-dependent or carrier-mediated. 3
  • The vitamin accumulates in the mucosal and submucosal layers of the large bowel during absorption. 3

Terminal Ileum (Secondary Site)

  • The terminal ileum contains reasonable concentrations of bacterial menaquinones where bile salt-mediated absorption is possible. 2
  • Direct human studies demonstrate that menaquinones delivered to the ileum are absorbed and produce measurable improvements in coagulation factors within 24 hours. 4
  • This distal small bowel location allows for efficient absorption of bacterially produced vitamin K2. 4

Clinical Significance of Bacterial Production

Contribution to Vitamin K Requirements

  • Bacterially synthesized menaquinones play a significant role in contributing to vitamin K requirements, especially during periods of dietary vitamin K deficiency. 5
  • The preponderance of evidence suggests that bacterial menaquinones can prevent clinically significant coagulopathy when dietary vitamin K1 is inadequate. 5
  • Hepatic stores contain predominantly long-chain menaquinones (MK-7 through MK-13), with approximately 60-70% being of bacterial origin. 2

Evidence from Antibiotic Studies

  • Patients receiving broad-spectrum antibiotics may develop coagulopathy (elevated prothrombin time), indirectly confirming that intestinal bacteria-produced menaquinones contribute to maintaining normal coagulation. 4
  • This clinical observation supports measuring vitamin K status in at-risk patients, including those on prolonged broad-spectrum antibiotics. 1

Important Clinical Caveats

Absorption Considerations

  • While bacterial synthesis occurs in the colon, the exact site and efficiency of menaquinone absorption from the gut microflora remains incompletely characterized. 2
  • Long-chain menaquinones are less well absorbed than shorter-chain forms, despite being bioactive in hepatic gamma-carboxylation. 2
  • The body requires continuous dietary supply of vitamin K1 (phylloquinone) because approximately 60-70% of daily intake is lost through excretion. 2

Dietary vs. Bacterial Sources

  • Vitamin K1 (phylloquinone) from green leafy vegetables and certain oils remains the primary dietary source and cannot be synthesized by bacteria. 1, 2
  • Fermented foods (especially cheeses) provide dietary menaquinones (MK-8 and MK-9) that are distinct from those produced by gut bacteria. 6, 2
  • The gut microflora produces a wider spectrum of menaquinones than those available from dietary sources. 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.